Beneficiary Profile: Victor Chang

Cardiovascular disease is the number one cause of death globally and costs the Australian economy $12 billion each year. Every 12 minutes, one Australian dies from the disease. This is why the Victor Chang Cardiac Research Institute is dedicated to finding cures through their world class research.

Beneficiary Profile: Victor Chang

October 12, 2020
Cardiovascular disease is the number one cause of death globally and costs the Australian economy $12 billion each year. Every 12 minutes, one Australian dies from the disease. This is why the Victor Chang Cardiac Research Institute is dedicated to finding cures through their world class research.
Read Transcript

Cardiovascular disease is the number one cause of death globally and costs the Australian economy $12 billion each year. This is projected to increase to $22 billion over the next decade. Cardiovascular disease has reached pandemic proportions with one Australian dying from the disease every 12 minutes. This is why scientists and doctors at the Victor Chang Cardiac Research Institute, Australia’s home of heart research, are dedicated to finding cures through their world class research.   

2019 was a landmark year with the Victor Chang Cardiac Research Institute celebrating 25 years of scientific achievements.  Over the last 25 years, the Victor Chang Cardiac Research Institute has made a multitude of major advances in heart research, many revolutionising our understanding of disease causes, treatment, and prevention in the areas of heart attack, cholesterol, heart arrhythmia, cardiomyopathy, congenital heart disease and  genetic analysis.

A new era for the Institute began in March 2020 as they welcomed Professor Jason Kovacic. A highly respected cardiologist and researcher, Professor Kovacic relocated from Mount Sinai Hospital in New York to take the reins as the Executive Director of the Victor Chang Cardiac Research Institute, and is the inaugural Robert Graham Professor of Cardiovascular Research. Named in honour of the Institute’s Founding Executive Director, this prestigious Chair position is generously supported by HM1 and provides critical ongoing funding to foster scientific excellence for the Institute.

Helped by partners like HM1 and Magellan, the Institute’s Innovation centre is heralding a research revolution in our search to solve the unsolved. It is pushing the boundaries of knowledge by transforming the landscape of cardiovascular research around Australia and the Asia Pacific. The Institute’s world class technology is accelerating the opportunities of discovering cures for heart disease and bringing us closer to realising “personalised” medicine of the future and improving health outcomes for patients suffering from heart disease in Australia and around the world. 

As part of our impact video series, we spoke with Founding Executive Director Professor Robert Graham and Professor Sally Dunwoodie, Head of Embryology, discussing the importance of medical research and their recent breakthroughs. You can watch the video below:

Cardiovascular disease is the number one cause of death globally and costs the Australian economy $12 billion each year. This is projected to increase to $22 billion over the next decade. Cardiovascular disease has reached pandemic proportions with one Australian dying from the disease every 12 minutes. This is why scientists and doctors at the Victor Chang Cardiac Research Institute, Australia’s home of heart research, are dedicated to finding cures through their world class research.   

2019 was a landmark year with the Victor Chang Cardiac Research Institute celebrating 25 years of scientific achievements.  Over the last 25 years, the Victor Chang Cardiac Research Institute has made a multitude of major advances in heart research, many revolutionising our understanding of disease causes, treatment, and prevention in the areas of heart attack, cholesterol, heart arrhythmia, cardiomyopathy, congenital heart disease and  genetic analysis.

A new era for the Institute began in March 2020 as they welcomed Professor Jason Kovacic. A highly respected cardiologist and researcher, Professor Kovacic relocated from Mount Sinai Hospital in New York to take the reins as the Executive Director of the Victor Chang Cardiac Research Institute, and is the inaugural Robert Graham Professor of Cardiovascular Research. Named in honour of the Institute’s Founding Executive Director, this prestigious Chair position is generously supported by HM1 and provides critical ongoing funding to foster scientific excellence for the Institute.

Helped by partners like HM1 and Magellan, the Institute’s Innovation centre is heralding a research revolution in our search to solve the unsolved. It is pushing the boundaries of knowledge by transforming the landscape of cardiovascular research around Australia and the Asia Pacific. The Institute’s world class technology is accelerating the opportunities of discovering cures for heart disease and bringing us closer to realising “personalised” medicine of the future and improving health outcomes for patients suffering from heart disease in Australia and around the world. 

As part of our impact video series, we spoke with Founding Executive Director Professor Robert Graham and Professor Sally Dunwoodie, Head of Embryology, discussing the importance of medical research and their recent breakthroughs. You can watch the video below:

Disclaimer: This material has been prepared by Victor Chang Cardiac Research Institute, published on October 12, 2020. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
April 20, 2023

Artificial intelligence gives new hope for sufferers of severe heart problem

New AI software can improve the diagnosis of severe aortic stenosis by 72% and could potentially change the lives of about 50,000 Australians with the life-threatening condition.

Read More
February 14, 2023

Bringing Equity and Diversity to Genomic Medicine

Professor Daniel MacArthur, Director of the Centre for Population Genomics has big goals to bring equity and diversity into genomic medicine in Australia, something surprisingly inadequate presently.

Read More
September 6, 2022

VCCRI: 'Heart in a Box'

An Australian method of preserving donated hearts has boosted the number of successful transplants across the world, with new research demonstrating similar survival rates to traditional transplants.

Read More
February 24, 2022

Impact Video: Cerebral Palsy Alliance

This video features Professor Nadia Badawi AM, Professor Alistair McEwan, Paul Rayson and others discussing the incredible impact our partnership will have.

Read More
February 24, 2022

New Partnership with Cerebral Palsy Alliance

We’re excited to announce a new partnership with the Cerebral Palsy Alliance and are proud to be supporting this important research.

Read More
August 3, 2021

Australian breakthrough to stop heart arteries from clogging

Victor Chang scientist has led landmark research that has the potential to stop arteries of the heart from becoming clogged by targeting a particular gene.

Read More
September 23, 2020

Silent wave' of brain damage could follow pandemic

Australia urgently needs to prepare for a "silent wave" of COVID-19, which appears to be taking the form of long-term neurological side effects following infection with the virus.

Read More
September 8, 2020

Beneficiary Profile: Black Dog Institute

1 in 5 of us will experience symptoms of mental illness in any given year. In Australia that’s around 5 million people. And roughly 60% of these people won’t seek help. Learn what Black Dog is doing to create a mentally healthier world for everyone.

Read More
August 10, 2020

Beneficiary Profile: RPA Green Light

Emergency departments are the frontline of health care, with one in seven Australians seeking help from a hospital emergency department every year. Our medical staff depend on research findings to help inform their responses to urgent patient needs.

Read More
July 7, 2020

Beneficiary Profile: The Florey

Every year, 4.7 million Australians are diagnosed with one of the conditions that the Florey study. That's why they believe everyone has a stake in medical research.

Read More
June 9, 2020

Beneficiary Profile: Orygen

1 in 5 young people will have experienced a depressive episode by the time they are 18. With thanks to Cooper Investors and Hearts & Minds, we have been able to put youth mental health on the global agenda and progress our work in developing a global mental health framework.

Read More
November 22, 2019

Impact Video Series: Sydney Children's Hospital Foundation

We interviewed leading individuals from our beneficiaries to discuss the importance of medical research, their recent breakthroughs and the vital need for private funding.

Read More
May 29, 2019

Winning Hearts and Minds

Mark Nelson of Caledonia discusses his connection with the Florey Institute, one of our beneficiaries, and why he's involved with Hearts and Minds.

Read More